JPMorgan Chase & Co. cut its position in shares of Exantas Capital Corp (NYSE:XAN) by 5.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 130,949 shares of the company’s stock after selling 6,936 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.41% of Exantas Capital worth $362,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in XAN. Sunbelt Securities Inc. bought a new stake in Exantas Capital in the fourth quarter worth about $2,657,000. Bank of Montreal Can raised its position in shares of Exantas Capital by 26.2% in the fourth quarter. Bank of Montreal Can now owns 5,778 shares of the company’s stock valued at $68,000 after purchasing an additional 1,198 shares during the period. Summit Global Investments raised its position in shares of Exantas Capital by 2.3% in the fourth quarter. Summit Global Investments now owns 80,505 shares of the company’s stock valued at $951,000 after purchasing an additional 1,800 shares during the period. Swiss National Bank raised its position in shares of Exantas Capital by 3.4% in the fourth quarter. Swiss National Bank now owns 60,900 shares of the company’s stock valued at $719,000 after purchasing an additional 2,000 shares during the period. Finally, Great West Life Assurance Co. Can bought a new stake in shares of Exantas Capital in the fourth quarter valued at approximately $25,000. Institutional investors and hedge funds own 68.96% of the company’s stock.
Exantas Capital stock opened at $2.65 on Wednesday. The firm’s 50 day simple moving average is $2.51 and its 200 day simple moving average is $7.00. The company has a current ratio of 270.63, a quick ratio of 270.63 and a debt-to-equity ratio of 5.04. The firm has a market capitalization of $82.35 million, a PE ratio of -0.47 and a beta of 1.39. Exantas Capital Corp has a 1-year low of $0.95 and a 1-year high of $12.51.
Several research firms have recently issued reports on XAN. Zacks Investment Research raised shares of Exantas Capital from a “sell” rating to a “hold” rating in a research report on Saturday. ValuEngine raised shares of Exantas Capital from a “strong sell” rating to a “sell” rating in a research report on Monday, June 1st. JMP Securities decreased their target price on shares of Exantas Capital from $13.00 to $4.00 and set a “market outperform” rating on the stock in a report on Tuesday, May 12th. Finally, Raymond James lowered shares of Exantas Capital from an “outperform” rating to a “market perform” rating in a report on Monday, April 13th.
About Exantas Capital
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments.
See Also: What is the cash asset ratio?
Want to see what other hedge funds are holding XAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exantas Capital Corp (NYSE:XAN).
Receive News & Ratings for Exantas Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exantas Capital and related companies with MarketBeat.com's FREE daily email newsletter.